Clinical trial data and design are being reevaluated in the context of decentralization. The shift towards decentralized clinical trials is prompting discussions on data collection, management, and governance, as well as the role of technologies like blockchain. The implications of these changes are being explored from various perspectives, including clinical trial delivery, human rights, and biospecimens data governance.